The cardiovascular needle market in South and Central America is expected to grow from US$ 6.63 Million in 2021 to US$ 9.58 Million by 2028; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028.
The prevalence of cardiovascular conditions is significantly rising in developing countries due to shift in lifestyle, and the modernization of commercial, industrial, and residential infrastructure; the modernized facilities result in reduced physical activities. On the other hand, stress levels continue to rise among people. Thus, these factors are driving the prevalence of cardiovascular conditions in developing countries. Further, these countries are significantly developing their healthcare facilities and services and are heading toward technological advancements. As per the study Global Burden of Disease in the Lancet, ~10 deaths are associated with this disease, which is equivalent to ~6.4 million deaths. Thus, emerging countries provide significant opportunities for the cardiovascular needles market players; they can enter these untapped or less explored markets with cost-effective products during the forecast period.The COVID‐ 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South and Central America. It suffers from severe inequalities. With a vast population living in poverty, South and Central America continuously face widespread health problems due to overcrowding, limited sanitation, food insecurity, and unpredictable environmental conditions. Underfunded state‐run hospitals are the only source of medical care in the region. Brazil is in a critical situation due to COVID-1. Lack of resources has created more challenges in the region and has affected number of cardiovascular procedures in the countries as healthcare setting were prioritizing treatment for COVID infected patients. All these factors will restrict the distribution and adoption of cardiac surgical instruments which will restrict the market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the cardiovascular needle market. The South and Central America cardiovascular needle market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
South and Central America Cardiovascular Needle Market Segmentation
By Application
- Open Heart Surgery
- Cardiac Valve Procedures
By Usage
- Single Use
- Multiple Uses
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centres
- Cardiovascular Centres
By Country
- South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Companies Mentioned
- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barber of Sheffield
- FSSB surgical needles GmbH
- Medtronic
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
South and Central America Cardiovascular Needle Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 6.63 Million |
Market Size by 2028 | US$ 9.58 Million |
Global CAGR (2021 - 2028) | 5.4% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | South and Central America
|
Market leaders and key company profiles |
|
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends

















